CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Biomarker
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
    Technologies and Software
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Takeda

Brenda Finkelstein, Head of Data, Digital & Technology | México

Driving Digital Transformation in Pharma: Innovation, Challenges and Future Trends

Brenda Finkelstein

Brenda Finkelstein

Pharmaceutical Digital Authority

Brenda’s Career Journey to Takeda


My career journey has been marked by a diverse range of experiences and roles that have led me to my current position as the DD&T Head at Takeda in Mexico. I have over 15 years of experience as a versatile Business Executive, with a strong foundation in international business development and strategic marketing.


I studied International Studies in Argentina and I have an MBA from Tel Aviv University. I started my career working with startups and then as a Consultant for the Swedish Trade Council, where I executed and led international business development projects. After my MBA, I moved into the pharmaceutical industry with positions at Janssen and Shire, where I managed product strategies and launches for various therapeutic areas.


At Takeda, I progressed from a Sr. Product Manager for the GI Therapeutic Area in Argentina to the Strategy Head for the South Cone Andean & Mexico regions. In this role, I led digital transformation strategies and innovation programs. My passion for leveraging digital technologies and data analytics to drive customer engagement and improve patient outcomes has been a consistent theme throughout my career. This trajectory of building high-performing teams and driving strategic initiatives has culminated in my current role, where I am responsible for driving creative disruption through digital technologies and data analytics at Takeda in Mexico.


Digital Advancements Shaping the Future of Healthcare


In the biotech and pharmaceutical sectors, digital innovations are transforming healthcare dramatically. AI and machine learning are revolutionizing drug discovery by predicting outcomes and personalizing treatments, while telemedicine is making healthcare more accessible and cost-efficient through virtual consultations. Big data analytics help identify disease patterns and tailor therapies, while block chain ensures secure and transparent data management. Additionally, wearable technology provides realtime health monitoring, fostering proactive healthcare. These advancements are making healthcare more efficient, personalized and accessible than ever before.


How Takeda is Leveraging Innovation and Digital Transformation


Takeda is at the forefront of innovation and digital transformation to enhance patient outcomes. We're harnessing advanced data analytics and artificial intelligence to revolutionize drug discovery and development, allowing for more precise and personalized therapies. Additionally, through digital health solutions and collaborations, we're expanding access to healthcare, ensuring patients receive timely and effective treatments. Integrating cutting-edge technology is central to Takeda’s mission to deliver better health for patients worldwide.


Challenges in The Global Pharmaceutical Landscape


Navigating the global pharma scene comes with its fair share of challenges—like dealing with complex regulations, tough competition and the constant push to innovate. Plus, there’s always the juggling act of managing pricing pressures while trying to make medicines accessible everywhere.

Fostering a culture of innovation is key—encourage creativity and openmindedness so your team feels free to explore new tech without fearing failure


To tackle these, Takeda focuses heavily on innovation, particularly in areas like oncology, gastro and rare diseases where new treatments can make a massive impact. We're also diving deep into digital transformation to streamline operations and enhance patient care.


Our Innovation Capability Centers (ICCs) play a huge role by fostering collaboration and leveraging cutting-edge tech to fasttrack solutions. Importantly, we’ve sharpened our strategic focus and prioritization efforts, making us more agile and adaptive in this dynamic landscape. This approach helps us stay nimble, ready to respond quickly to changes and continue delivering topnotch, patient-focused healthcare solutions.


Advice for Leaders Integrating Emerging Technologies


Integrating emerging technologies while keeping up with regulatory compliance is quite the balancing act for leaders in the pharma industry. Here’s my take:


First off, stay in the loop. It’s essential to keep up with both the latest tech trends and the changing regulatory landscape. This knowledge is crucial for successful integration.


Fostering a culture of innovation is key. Encourage creativity and open-mindedness, so your team feels free to explore new tech without fearing failure.


You also need to invest in talent and training. Make sure your team has the skills to make the most of new technologies and understand the regulatory side of things.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.

Editorial Lens

Digital transformation in pharmaceuticals demands more than technological adoption, requiring life sciences leaders to balance innovation, regulatory responsibilities and measurable improvements in patient care. Brenda Finkelstein’s perspective highlights the leadership judgment, organizational adaptability and investment in digital capabilities needed to translate emerging technologies into meaningful healthcare advancements.

The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    UPS [NYSE:UPS]

    Four Myths about Innovation in Logistics

    Daniel Gagnon, Vice President, Global Healthcare Strategy and Marketing

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent-Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition

  • Willis Towers Watson

    Abivax [EPA: ABVX]

    Leveraging Technological Advancements for Developing Innovative Therapeutics

    Marc de Garidel, CEO and Interim Chairman, Abivax

  • Willis Towers Watson

    Cordlife Group Limited [SGX: P8A]

    Cord Blood Transplantation: A Lifesaving Resource Overview

    Zhu Pengcheng, PhD, Laboratory & Technical Director, Group Lab Operations and David Leung, PhD, FIBMS, MRSB, CBiol, CSci, CQA(ASQ), CLSSBB, Laboratory Director, Cordlife Group Limited, Singapore

{literal}{/literal}
Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/brenda-finkelstein-nwid-3868.html